Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Lung Neoplasms 8 Colorectal Neoplasms 6 Hematologic Neoplasms 5 Prostatic Neoplasms 4 Hodgkin Disease 4 Carcinoma, Non-Small-Cell Lung 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Motor Activity 3 Pancreatic Neoplasms 2 Obesity 2 Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Hematopoietic and Lymphoid System Neoplasm 2 Gastrointestinal Diseases 2 Cardiotoxicity 2 Urinary Bladder Neoplasms 1 Trastuzumab Cardiotoxicity 1 Stress Disorders, Post-Traumatic 1 Small Cell Lung Carcinoma 1 Sleep Wake Disorders 1 Sedentary Behavior 1 Sarcopenia 1 Radiation Pneumonitis 1 Radiation Fibrosis Syndrome 1 Polycystic Ovary Syndrome 1 Pelvic Neoplasms 1 Pathologically Proven Gastrointestinal Malignancy 1 Oropharyngeal Neoplasms 1

Interventions

pembrolizumab 300 Nivolumab 273 Ipilimumab 250 aldesleukin 137 Cyclophosphamide 135 Interleukin-2 105 trametinib 82 dabrafenib 76 Temozolomide 75 Dacarbazine 74 Vemurafenib 71 fludarabine 67 fludarabine phosphate 61 Biopsy 49 binimetinib 47 sargramostim 44 Radiosurgery 44 Bevacizumab 43 Paclitaxel 42 encorafenib 40 incomplete Freund's adjuvant 39 atezolizumab 38 Radiotherapy 37 Cisplatin 36 CTLA-4 Antigen 36 Carboplatin 35 cobimetinib 34 Specimen Handling 34 Magnetic Resonance Spectroscopy 34 Introns 33

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × Exercise Test × Clear all

NCT06008977 2026-03-25

EX-BOOST

AdventHealth Translational Research Institute

Phase NA Active not recruiting

Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡